Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Eosinophils in transbronchial biopsies: a predictor of chronic lung allograft dysfunction and reduced survival after lung transplantation - a retrospective single-center cohort study.
Darley DR, Ma J, Huszti E, Fiset P, Levy L, Hwang DM, Pal P, Klement W, Zamel R, Keshavjee S, Tomlinson G, Singer LG, Tikkanen JM, Martinu T. Darley DR, et al. Among authors: huszti e. Transpl Int. 2021 Jan;34(1):62-75. doi: 10.1111/tri.13760. Epub 2020 Nov 16. Transpl Int. 2021. PMID: 33025592 Free article.
Epithelial cell death markers in bronchoalveolar lavage correlate with chronic lung allograft dysfunction subtypes and survival in lung transplant recipients-a single-center retrospective cohort study.
Levy L, Tigert A, Huszti E, Saito T, Mitsakakis N, Moshkelgosha S, Joe B, Boonstra KM, Tikkanen JM, Keshavjee S, Juvet SC, Martinu T. Levy L, et al. Among authors: huszti e. Transpl Int. 2019 Sep;32(9):965-973. doi: 10.1111/tri.13444. Epub 2019 May 15. Transpl Int. 2019. PMID: 31002407 Free article.
Risk assessment of chronic lung allograft dysfunction phenotypes: Validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system.
Levy L, Huszti E, Renaud-Picard B, Berra G, Kawashima M, Takahagi A, Fuchs E, Ghany R, Moshkelgosha S, Keshavjee S, Singer LG, Tikkanen J, Martinu T. Levy L, et al. Among authors: huszti e. J Heart Lung Transplant. 2020 Aug;39(8):761-770. doi: 10.1016/j.healun.2020.04.012. Epub 2020 Apr 19. J Heart Lung Transplant. 2020. PMID: 32418864
Bronchoalveolar bile acid and inflammatory markers to identify high-risk lung transplant recipients with reflux and microaspiration.
Zhang CYK, Ahmed M, Huszti E, Levy L, Hunter SE, Boonstra KM, Moshkelgosha S, Sage AT, Azad S, Zamel R, Ghany R, Yeung JC, Crespin OM, Frankel C, Budev M, Shah P, Reynolds JM, Snyder LD, Belperio JA, Singer LG, Weigt SS, Todd JL, Palmer SM, Keshavjee S, Martinu T; CTOT-20 investigators. Zhang CYK, et al. Among authors: huszti e. J Heart Lung Transplant. 2020 Sep;39(9):934-944. doi: 10.1016/j.healun.2020.05.006. Epub 2020 May 19. J Heart Lung Transplant. 2020. PMID: 32487471 Free PMC article.
The accuracy of forced vital capacity for diagnosing restrictive allograft syndrome and mixed phenotype of chronic lung allograft dysfunction.
Levy L, Huszti E, Berra G, Renaud-Picard B, Kawashima M, Takahagi A, Moshkelgosha S, Ghany R, Fuchs E, Chow CW, Keshavjee S, Singer LG, Tikkanen J, Martinu T. Levy L, et al. Among authors: huszti e. Eur Respir J. 2021 Jul 20;58(1):2003387. doi: 10.1183/13993003.03387-2020. Print 2021 Jul. Eur Respir J. 2021. PMID: 34172465 Free article. No abstract available.
Bronchoalveolar lavage cytokine-based risk stratification of minimal acute rejection in clinically stable lung transplant recipients.
Levy L, Huszti E, Ahmed M, Ghany R, Hunter S, Moshkelgosha S, Zhang CYK, Boonstra K, Klement W, Tikkanen J, Singer LG, Keshavjee S, Juvet S, Martinu T. Levy L, et al. Among authors: huszti e. J Heart Lung Transplant. 2021 Dec;40(12):1540-1549. doi: 10.1016/j.healun.2021.05.017. Epub 2021 May 29. J Heart Lung Transplant. 2021. PMID: 34215500
100 results